Industry News

Globe Scientific Acquired by L Squared Capital Partners

By Labmedica International staff writers
02 May 2022

Image: L Squared Capital Partners has acquired Globe Scientific (Photo courtesy of Pexels)

Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.

GSI Group is a collection of brands serving the biotech, clinical diagnostics, life sciences, education, and industrial sectors. With more than USD 100 million in revenue, GSI Group’s brands collectively offer a broad array of mission-critical lab-related consumable supplies, benchtop equipment, and related accessories to research, laboratory, clinical, academic, and industrial institutions across the world. GSI Group is aggressively pursuing acquisitions that provide chemicals and reagents, general and life science consumables, kits used in molecular biology applications, lab glassware, analytical instruments, and benchtop lab equipment to its target customer base. GSI Group is also seeking to expand its presence in high growth end markets such as biopharma, molecular diagnostics, and food safety testing. With its acquisition, Globe Scientific joins the existing GSI Group brands AmScope, Euromex, Omax, and Physix.

“My family and I are excited to partner with L Squared to become part of the GSI Group platform,” said Dara Diamond, President and CEO. “For the past 38 years, we have been passionate about providing a family-oriented culture for our employees while delivering five-star service and value to our customers and supply-chain partners. We are thrilled to join a platform of companies that share the same passion, vision, and corporate culture mindset.”

“Globe Scientific is an excellent addition to our consolidation thesis. We remain bullish on the long-term growth trajectory of scientific research and proud to be building a platform that supplies key products to the life sciences, clinical diagnostic, and academic research sectors,” said Randall Hunt, Partner at L Squared. “We are committed to supporting GSI Group’s growth both organically as well as via acquisitions of additional leading brands in the marketplace.”

Related Links:
Globe Scientific 
L Squared Capital Partners 

E-mail Print
FaceBook Twitter Google+ Linked in


Globe Scientific, Inc. is an ISO 9001:2015 certified worldwide supplier of high-quality laboratory plasticware, glassware and bench-top equipment and offers the most extensive lines of products for clinical, research, education, veterinary and industrial laboratories. The company is continuously expanding its product line based on the needs of its customers and offers the broadest selection of laboratory products from any one source with over 3,500 items available for immediate shipment.
More info

More articles about GLOBE SCIENTIFIC

01 Mar 2022
Globe Scientific Unveils New Laboratory Glassware Line with Superior Packaging
Globe Scientific (Mahwah, NJ, USA) has launched Globe Glass premium quality laboratory glassware with superior GlassGuard packaging that is designed to meet the needs of both laboratory professionals and laboratory supply distributors.
Read More

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 All rights reserved. | Terms And Conditions